-

Schrödinger to Host Conference Call to Discuss Fourth Quarter and Year-End 2020 Financial Results

NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that it will host a conference call and webcast on Thursday, March 4, 2021, at 8:30 a.m. ET to discuss fourth quarter and year-end 2020 financial results and provide a general business update.

The live webcast can be accessed under "News & Events" in the investors section of Schrödinger’s website. To participate in the live call, please dial (833) 727-9520 (domestic) or +1 (830) 213-7697 (international) and refer to conference ID 9686253. The archived webcast will be available on Schrödinger’s website for approximately 90 days following the event.

About Schrödinger
Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages its software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.

Founded in 1990, Schrödinger has over 450 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com and follow us on LinkedIn and Twitter.

Contacts

Jaren Madden
Schrödinger, Inc.
jaren.madden@schrodinger.com
617-286-6264

Stephanie Simon (media)
Ten Bridge Communications
stephanie@tenbridgecommunications.com
617-581-9333

Schrödinger

NASDAQ:SDGR

Release Summary
Today Schrödinger announced that it will host a conference call and webcast on Thursday, March 4, 2021, at 8:30 a.m. ET.
Release Versions

Contacts

Jaren Madden
Schrödinger, Inc.
jaren.madden@schrodinger.com
617-286-6264

Stephanie Simon (media)
Ten Bridge Communications
stephanie@tenbridgecommunications.com
617-581-9333

More News From Schrödinger

Schrödinger to Present at the H.C. Wainwright Global Life Sciences Conference

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that management will provide a corporate overview during the H.C. Wainwright Global Life Sciences Conference....

Schrödinger Expands Agreement with Google Cloud to Further Bolster Its Drug Discovery and Materials Science Initiatives

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced it has expanded its collaboration with Google Cloud....

Schrödinger to Present at the SVB Leerink Partners 10th Annual Global Healthcare Conference

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that management will provide a corporate overview at the SVB Leerink Partners 10th Annual Global Healthcare Conference....
Back to Newsroom